Candy Manufacturer Haribo Recalls Sweets After Cannabis Found In Them
The recall applies to the items under the production code L341-4002307906, with a best before date of January 2026. Haribo added that a full refund would be provided for the packs returned, according to a report in The Guardian.
"There are bags in circulation with sweets that can lead to health complaints, such as dizziness, when consumed," NVWA spokesperson Saida Ahyad said.
"The police reported this to the NVWA after several people, both children and adults, became ill after eating the cola bottles. Do not eat the sweets," she added.
According to the Dutch police, a couple from the Twente region in the east of the country bought a pack of the cola-bottle shaped sweets to the local police station for analysis after their young children became sick after eating them. The forensic analysis revealed that the candy pack did contain cannabis.
'We want to know exactly how it got into the candy and, of course, how the bags ended up in the store,' police spokesperson Chantal Westerhoff said.
Haribo issued a statement, stating it was working with the authorities to find out how the marijuana was added to its products.
"This is a live issue and we are working closely with the Dutch authorities to support their investigation and establish the facts," said Haribo's vice president of marketing, Patrick Tax.
"The safety of our consumers is our highest priority, and Haribo takes this incident very seriously."
This is not the first instance when drugs have been found in children's sweets. In 2023, six children got sick in The Hague after eating candy containing THC, one of the active ingredients in cannabis. As per police officials, drug smugglers are increasingly using candies as a cover to move their product and lacing them with THC and other compounds.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Top US doc reveals 4 skin changes that could mean liver disease
Liver disease claims about two million lives annually, which is 4% of all deaths (1 out of every 25 deaths worldwide), according to a 2023 . Among this, approximately two-thirds of all liver-related deaths occur in men. Tired of too many ads? go ad free now Cirrhosis and hepatocellular carcinoma are the major causes of death, of which the former is linked to viral hepatitis, alcohol, and non-alcoholic fatty liver disease. Early detection is crucial for identifying liver diseases. Dr. Saurabh Sethi, a leading California-based gastroenterologist, has raised awareness about a few overlooked signs, which start with your skin. 'You can check these at home,' the liver specialist said. Here are four signs of liver disease that appear on the skin. Watch out for these signs. Yellowing of the skin and eyes/ Jaundice Jaundice is the first and most evident sign of liver disease. You may notice yellowing of the skin and eyes. 'This is a classic sign of liver disease,' the doctor said in a shared on Instagram. Dr. Sethi explained that the yellowing of the skin and eyes occurs due to elevated levels of bilirubin. It is a yellow pigment produced during red blood cell breakdown. The liver is responsible for the processing of bilirubin; however, when it dysfunctions, this pigment builds up in the system, leaving the skin and eyes yellow. If you notice this sign, it is important to seek immediate medical attention. Spider angiomas Another crucial sign of liver dysfunction is the appearance of spider angiomas. Dr. Sethi explains that these are small, dilated blood vessels that resemble spider webs, which typically appear on the face, neck, or chest. Tired of too many ads? go ad free now The doctor noted that these spider webs are formed due to the increased levels of estrogen, which can result from liver dysfunction. The liver is responsible for metabolizing hormones. But when it does not function properly, these hormones, including estrogen, can build up. Palmar erythema One sign that people tend to overlook is redness and inflammation of the palms. This condition is called palmar erythema. Dr. Sethi added that this symptom is often accompanied by swelling. ' This is due to increased blood flow and estrogen levels, which can be a sign of liver dysfunction,' Dr. Sethi said. One may find their palms look flushed and red, and may also experience warmth. This symptom is often overlooked or mistaken for physical strain or other skin issues. 7 Ways to check for fatty liver at home Itching Itching of the skin is another warning sign that your liver is not functioning properly. This symptom may worsen at night. Dr. Sethi explained that itching happens due to the buildup of bile salts in the skin. This itch is different from dry skin or allergies. It often lingers longer and could significantly affect your life. If the itching is accompanied by other symptoms, it's a warning sign. Disclaimer: This information is intended for general knowledge only and should not be used as a substitute for professional medical advice, diagnosis, or treatment.
Time of India
3 hours ago
- Time of India
53% of Indian Youths Are ‘Personality Malnourished': Study
1 2 Nagpur: India is often called a young country, with nearly 26 crore people between the ages of 18 and 29. This is seen as our greatest strength. However, a new study brings serious concern — 53% of Indian youth are 'personality malnourished'. This means their overall growth as individuals is not happening well — they are missing important life skills, emotional strength, and social values, the study found. This study was conducted by Amrut Bang, project director of NIRMAN, who presented three research papers at the Emerging Adulthood Conference held in Charleston, USA, recently. NIRMAN is a youth educational initiative started under Gadchiroli-based NGO SEARCH (Society for Education, Action, Research in Community Health). Bang's key paper is based on research involving 4,283 young people between 2021 and 2024. The conference focused on the life phase of Emerging Adulthood (18 to 29 years) — a time when young people explore their identity and build their future. The term was introduced by psychologist Jeffrey Arnett, who also attended the conference with over 300 researchers from across the world. "The National Education Policy 2020 calls for the complete, all-round development of youth. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Where Your Search Ends Hotel Deals | Search Ads Browse Now Undo NIRMAN has developed a way to measure this overall growth," said Bang. "Our research clearly shows that more than half of Indian youth are malnourished in their personality. This is a big concern that needs attention." He added, "While 35% of Indian children are physically malnourished, 53% of youth are personality malnourished. This is an even bigger problem." There were 50 questions in total. If a youth scored poorly in two-thirds (2/3) of the questions in any one area, they were considered personality malnourished in that domain. The study found that 53% of youth were personality malnourished in four or more areas. Only 9% showed good growth in all seven important areas of life. "We have tools to check if a child is growing well physically. In the same way, we need tools to check if our youth are growing well as people. That's why we created this method," said Bang. # How is Personality Malnourishment Measured? NIRMAN developed a simple method to check the overall growth of youth in seven important life areas: - Physical health - Mental health - Character and values - Relationships - Professional growth - Life skills - Social contribution More Insights Amrut Bang also presented two more studies: - The Emotional World of Indian Youth: A study on the most common emotions experienced by Indian youth - The Questions Indian Youth Are Asking: Based on 6,100 real questions from young people. The most frequently asked question: 'Who am I, and what is the purpose of my life?'
Economic Times
7 hours ago
- Economic Times
Cheaper cancer care therapy earns big bucks for pharma company
India's cell and gene therapy pioneer ImmunoAct has turned profitable in its first full year of operations, a rare feat in the country's emerging startup landscape where research-based pharma enterprises encounter serious scale and cash flow challenges. ImmunoACT, in which Hyderabad-based drugmaker Laurus Labs has roughly 34% equity stake, saw revenues of ₹62 crore with a profit before tax of ₹12 crore in FY25, according to sources. The year before, ImmunoAct had revenues of ₹11 crore. Founded by immunologist Rahul Purwar in 2013, ImmunoACT was spun off from the department of bioengineering department of IIT Bombay in 2018. ImmunoACT's NexCAR19 is the first indigenously developed breakthrough cancer CAR-T (chimeric antigen receptor T-cell) therapy approved by India's central drug regulatory agency in October 2023. NexCAR19 was formally launched in India in April 2024 at a price ~90% cheaper than its US and European counterparts like Novartis and Gilead, making it far more affordable for India and low-and-middle income countries, on its potential approval. So far, the therapy has been infused in over 350 patients across 70 hospitals in India. In CAR-T treatment, the patient's immune cells are extracted and through a maze of re-engineering processes infused back to recognize and kill cancer cells, giving a longer remission to patients as compared to the conventional options like immunotherapy or bone marrow transplants. The therapy is used when all other options are CAR-T dose (one-and-done infusion) costs around ₹30 lakh, which was initially priced at ₹42 lakh, and is expected to see a further decline as demand picks ImmunoACT has recently appointed former managing director of Roche India V Simpson Immanuel as its strategic Purwar added, "We needed someone who understands not just the commercial landscape, but also the nuances of innovation, patient access, and global expansion." Earlier this year, Immuneel Therapeutics, backed by leading names like Kiran Mazumdar-Shaw and globally renowned oncologist Siddhartha Mukherjee secured approval for Qartemi, its cell therapy for adult B-cell non-Hodgkin Lymphoma, in India. Companies like Cipla, Dr Reddy's Labs and Bharat Biotech are investing heavily in new CAR-Ts. Globally, CAR-Ts are at the frontiers of a range of cancer treatments, attracting billions of dollars in investments from large drugmakers. The market for such therapies is expected to touch $134 billion by 2034 from around $10 billion at present.
